DGIST presents a pathology model that will open up the possibility of early treatment for degenerative brain diseases
[금일 제약업계 주요기사]Celltrion, Corona 19 Antibody Treatment Phase 2 Results… Seegene, global business expansion’Start’, etc.
Celltrion unveils the results of phase 2 clinical trials for corona antibody treatment for the first time on the 13th
Health and Medical Union “Preferential treatment for reexamination of medical students who refused the national government